✦ LIBER ✦

Oncogenic Signals as Treatment Targets in Classic Myeloproliferative Neoplasms

✍ Scribed by Ayalew Tefferi; Ross L. Levine; Hagop Kantarjian

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The mTOR signaling pathway as a treatmen

✍ Pachow, D.; Wick, W.; Gutmann, D. H.; Mawrin, C. 📂 Article 📅 2014 🏛 Duke University Press 🌐 English ⚖ 252 KB

Comparison of mutated ABL1 and JAK2 as o

✍ Walz, C; Cross, N C P; Van Etten, R A; Reiter, A 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 246 KB

PCM1–JAK2-fusion: a potential treatment

✍ Hoeller, Sylvia; Walz, Christoph; Reiter, Andreas; Dirnhofer, Stephan; Tzankov, 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 566 KB

[Advances in Experimental Medicine and B

✍ El-Deiry, Wafik S 📂 Article 📅 2012 🏛 Springer New York ⚖ 362 KB

Cell Death Signaling in Cancer Biology a

✍ Johnson, Daniel E. 📂 Article 📅 2012 🏛 Springer New York ⚖ 803 KB

A Possibility that AMF will Serve as a T

✍ Arayo Haga 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 8 KB